pcDNA3-OPN-V5 Citations (5)

Originally described in: Johnson Lab Plasmids
Unpublished

---

Articles Citing pcDNA3-OPN-V5

Articles
Osteopontin-integrin alpha(v)beta(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma. Nakamura T, Shinriki S, Jono H, Ueda M, Nagata M, Guo J, Hayashi M, Yoshida R, Ota T, Ota K, Kawahara K, Nakagawa Y, Yamashita S, Nakayama H, Hiraki A, Shinohara M, Ando Y. FEBS Lett. 2015 Jan 16;589(2):231-9. doi: 10.1016/j.febslet.2014.12.004. Epub 2014 Dec 10. PubMed
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Oncotarget. 2016 May 31;7(22):32156-71. doi: 10.18632/oncotarget.8537. PubMed
Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer. Wong JPC, Wei R, Lyu P, Tong OLH, Zhang SD, Wen Q, Yuen HF, El-Tanani M, Kwok HF. Int J Biol Sci. 2017 Nov 1;13(11):1373-1386. doi: 10.7150/ijbs.21457. eCollection 2017. PubMed
In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer. Wei R, Wong JPC, Lyu P, Xi X, Tong O, Zhang SD, Yuen HF, Shirasawa S, Kwok HF. J Cell Mol Med. 2018 Sep;22(9):4097-4105. doi: 10.1111/jcmm.13686. Epub 2018 May 30. PubMed
Loss of Vlk in Prx1(+) Cells Delays the Initial Steps of Endochondral Bone Formation and Fracture Repair in the Limb. Maridas DE, Gamer L, Moore ER, Doedens AM, Yu Y, Ionescu A, Revollo L, Whitman M, Rosen V. J Bone Miner Res. 2022 Apr;37(4):764-775. doi: 10.1002/jbmr.4514. Epub 2022 Feb 16. PubMed

If you have published an article using this material, please email us at to have your article added to this page.